Walk into any premium health food store or scroll through any wellness-forward NA drinks brand's social media and you'll encounter adaptogens: a category of plants, fungi, and herbs claimed to help the body "adapt" to stress, improve cognitive function, reduce anxiety, boost immunity, and enhance athletic performance — among a longer list of claimed benefits that tends to expand with the marketing budget. Ashwagandha, lion's mane, reishi, rhodiola, holy basil, schisandra — these are the familiar names in a category that has moved from specialist herbalism to mainstream consumer products with remarkable speed. The serious question — the one that marketing materials carefully sidestep — is: what does the clinical evidence actually say about adaptogens delivered in beverages, at the concentrations typical of commercial drinks products, in the populations likely to be consuming them? The answer is more complicated and more interesting than either the enthusiastic brands or the reflexive skeptics suggest.
What "Adaptogen" Actually Means
The term "adaptogen" was coined by Soviet pharmacologist Nikolai Lazarev in 1947, refined by colleague Israel Brekhman, and refers to substances that help organisms (originally, Soviet military personnel) better withstand physical and psychological stress. Brekhman and Dardymov formalized the definition in 1969: an adaptogen must be nontoxic at normal doses, produce a nonspecific resistance response (helping the body resist a wide range of stressors), and have a normalizing effect (moving physiological parameters toward homeostasis rather than pushing them in a single direction).
This definition is notably vague by modern pharmacological standards. "Nonspecific resistance" is not a mechanism — it's a description of an observed phenomenon. The scientific community has therefore been cautious about the adaptogen category, while traditional medicine systems (Ayurveda, Traditional Chinese Medicine, Russian folk medicine) have worked with many of these plants for centuries.
The honest scientific status: some adaptogens have good-quality evidence for specific effects at specific doses. Others have preliminary or weak evidence. Others are supported primarily by traditional use and in vitro studies that don't translate to meaningful human effects at typical consumer doses.
Ashwagandha (Withania somnifera): The Best Evidence
Ashwagandha is, by a significant margin, the adaptogen with the strongest clinical evidence base. Multiple randomized controlled trials (RCTs) have been published, and several systematic reviews have synthesized the evidence.
What the evidence actually shows:
**Cortisol reduction**: A 2012 RCT published in the *Indian Journal of Psychological Medicine* found that 300mg KSM-66 ashwagandha extract twice daily for 60 days produced significant reductions in serum cortisol (a stress hormone) compared to placebo. This finding has been replicated in multiple subsequent studies.
**Anxiety**: Multiple RCTs show significant anxiety reduction with ashwagandha extract at 300–600mg daily, compared to placebo. Effect sizes are modest to moderate — meaningful but not dramatic.
**Sleep quality**: A 2019 RCT found that 600mg/day ashwagandha root extract improved sleep quality, sleep onset latency, and morning alertness compared to placebo.
**Athletic performance**: Several RCTs support improvements in VO2 max, muscle strength, and recovery with 300–600mg/day dosing in trained adults.
The crucial question for beverage consumers: many commercial adaptogen drinks contain 50–100mg ashwagandha per serving, well below the 300–600mg doses used in clinical studies. Whether smaller doses produce meaningful effects is unclear. Some brands use standardized extracts (like KSM-66, which has the best evidence profile) at doses that may approach clinical relevance; most use much lower concentrations.
Lion's Mane Mushroom (Hericium erinaceus): Promising, Not Proven
Lion's mane has attracted scientific attention primarily for its potential cognitive benefits, mediated through compounds called hericenones and erinacines that appear to stimulate nerve growth factor (NGF) synthesis in the brain.
The evidence:
A 2009 RCT published in *Phytotherapy Research* found that lion's mane extract (750mg/day for 16 weeks) improved cognitive function scores in adults with mild cognitive impairment compared to placebo. This study is widely cited but has limitations: small sample size (30 participants), conducted in elderly Japanese subjects, and the cognitive improvement disappeared four weeks after stopping supplementation.
A 2023 study published in the *Journal of Neurological Science* found improvements in memory performance in healthy young adults with 1.8g/day of lion's mane for 12 weeks.
The honest picture: preclinical data (cell culture and animal studies) is quite compelling. Human clinical evidence exists but is limited in quantity and quality. The doses required appear to be several times higher than what's typically found in commercial drinks products.
Rhodiola Rosea: Stress and Fatigue Effects
Rhodiola rosea has the second-strongest evidence base after ashwagandha. Its primary active compounds (rosavins and salidroside) have been studied for anti-fatigue and anti-stress effects primarily in occupational contexts.
The most consistent finding: reduced fatigue under mental and physical stress. A systematic review and meta-analysis published in *Phytomedicine* in 2016 concluded that rhodiola had robust effects on fatigue and cognitive function under stress. The effective doses in these studies were typically 200–600mg of standardized extract daily.
Rhodiola has a somewhat stimulant-like quality compared to other adaptogens — it can increase alertness and reduce perceived fatigue more immediately than ashwagandha's longer-arc cortisol effects. This makes it a popular ingredient in functional drinks aimed at focus and performance.
Reishi (Ganoderma lucidum): Traditional Use, Weak Clinical Evidence
Reishi is one of the most revered mushrooms in Traditional Chinese Medicine, where it has been used for at least 2,000 years. The clinical evidence for human cognitive or stress effects in healthy adults is, however, weak.
What exists: some evidence for immune modulation (reishi polysaccharides appear to stimulate natural killer cell activity), some evidence for reduced fatigue in cancer patients undergoing treatment, and preliminary evidence for antioxidant effects. Claims about cognitive enhancement in healthy adults are not well-supported by clinical evidence.
Reishi is widely included in functional drinks for its brand value (it photographs beautifully, it has an impressive traditional pedigree, and its marketing story is compelling) more than for clinically meaningful effects at typical doses.
The Dose Problem in Beverages
This is the central issue that most adaptogen drink marketing carefully ignores. Clinical studies showing effects use standardized extracts at specific doses, typically delivered in capsule form to control bioavailability. A drink containing 50mg of ashwagandha root powder (not extract) alongside multiple other ingredients, consumed with food, in a beverage with carbonation that may affect absorption — this is a fundamentally different delivery system than a clinical trial capsule protocol.
The brands doing this most honestly use standardized, high-bioavailability extracts (KSM-66 ashwagandha, Sensoril, branded lion's mane extracts), disclose the exact form and dose on labeling, and don't overclaim effects.
The brands doing this least honestly use undisclosed "proprietary blends" that may contain minimal active ingredient, make sweeping wellness claims in marketing while technically complying with regulations that prohibit specific health claims, and leverage the aspirational wellness aesthetic without the substance.
What This Means for Zero-Proof Drink Consumers
Adaptogen drinks can be excellent zero-proof options regardless of whether their functional claims hold up at the doses included. Many of them taste interesting, are made with genuine care, and offer a sophisticated flavor experience. But buying them for their functional effects requires scrutiny that the marketing makes difficult.
The questions to ask: What specific ingredient and what specific form? ("Ashwagandha" tells you less than "300mg KSM-66 ashwagandha extract.") How does this dose compare to clinical studies? Is there a plausible delivery mechanism for the effect claimed?
Adaptogens are not pseudoscience. Several have meaningful evidence for specific effects at appropriate doses. The problem is that the distance between what the evidence supports and what the marketing implies is considerable — and closing that gap requires either better labeling, more honest marketing, or consumers who know enough about the science to ask the right questions. The drinks can be excellent. The claims deserve scrutiny. These two things are not in conflict.